Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm of Head of Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT04889742
What this trial is testing

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

Who this might be right for
Recurrent CancerProstate CancerCervical Cancer+7 more
Charite University, Berlin, Germany 110
Not applicableStudy completedNCT04188990
What this trial is testing

Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition

Who this might be right for
Pancreatitis, AcuteCrohn DiseaseUlcerative Colitis+5 more
Hospital Galdakao-Usansolo 1,051
Early research (Phase 1)Ended earlyNCT03621982
What this trial is testing

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more
ADC Therapeutics S.A. 78
Not applicableStudy completedNCT06980792
What this trial is testing

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

Who this might be right for
Pancreas NeoplasmsLiver MetastasisPancreas Ductal Adenocarcinoma+3 more
Azienda Ospedaliero-Universitaria di Modena 90
Testing effectiveness (Phase 2)Study completedNCT00534001
What this trial is testing

Bupropion in Helping Adults Stop Smoking

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
Roswell Park Cancer Institute 95
Early research (Phase 1)Study completedNCT02574663
What this trial is testing

TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors

Who this might be right for
Pancreatic CancerColorectal CancerRectal Cancer+3 more
TG Therapeutics, Inc. 66
Not applicableStudy completedNCT00511264
What this trial is testing

Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract

Who this might be right for
Esophageal CancerGastric CancerPancreatic Cancer+1 more
Odense University Hospital 250
Large-scale testing (Phase 3)Ended earlyNCT00332280
What this trial is testing

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Who this might be right for
Gastrointestinal CancerProstate CancerGenital Neoplasms, Female
Auron Healthcare GmbH 67
Testing effectiveness (Phase 2)Study completedNCT05259696
What this trial is testing

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

Who this might be right for
OncologyMelanomaOvarian Cancer+14 more
Palleon Pharmaceuticals, Inc. 69
Testing effectiveness (Phase 2)Ended earlyNCT00766636
What this trial is testing

Preoperative Chemotherapy (Gemcitabine and Erlotinib) With or Without Radiation Therapy

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 5
Not applicableWithdrawnNCT03358095
What this trial is testing

Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage?

Who this might be right for
Pancreatic CancerBiliary Stasis
Helsinki University Central Hospital
Not applicableUnknownNCT04440800
What this trial is testing

Feasibility of Wearable Activity Trackers for Detection of TOXicity in People Receiving Systemic Anticancer Treatment

Who this might be right for
Lung Cancer, Small CellPancreatic CancerGastric Cancer+3 more
Royal Marsden NHS Foundation Trust 50
Early research (Phase 1)Active Not RecruitingNCT06238479
What this trial is testing

LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 490
Early research (Phase 1)Not Yet RecruitingNCT07807956
What this trial is testing

Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNon-Small Cell Lung CancerColorectal Cancer+6 more
AbbVie 130
Not applicableLooking for participantsNCT01365169
What this trial is testing

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Who this might be right for
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more
M.D. Anderson Cancer Center 590
Not applicableLooking for participantsNCT07270237
What this trial is testing

Multiparametric Ultrasound Imaging Methods

Who this might be right for
Pancreatic CancerThyroid Nodule
Memorial Sloan Kettering Cancer Center 85
Early research (Phase 1)Not Yet RecruitingNCT07822399
What this trial is testing

MGC030 in Participants With Advanced Solid Tumors

Who this might be right for
Urothelial CancerGastroEsophageal CancerColorectal Cancer+3 more
MacroGenics 314
Not applicableLooking for participantsNCT05297734
What this trial is testing

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Who this might be right for
End of LifeCancer
Stanford University 2,996
Early research (Phase 1)Ended earlyNCT05432193
What this trial is testing

FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)

Who this might be right for
Pancreatic Ductal AdenocarcinomaColorectal CancerEsophageal Cancer+4 more
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company 20
Early research (Phase 1)UnknownNCT03507998
What this trial is testing

Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors

Who this might be right for
Colorectal AdenocarcinomaGastric AdenocarcinomaPancreatic Adenocarcinoma+4 more
Curegenix Inc. 39
Next Page